The influence of β2-glycoprotein I on tissue factor activity

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue 3, 1998, Pages 211-215

  Ieko, Masahiro ^a   Yasukouchi, Taro ^a   Sawada, Ken Ichi ^b   Toike, Takao ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Chromogenic assay; Tissue factor; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; CHROMOGENIC SUBSTRATE; PHOSPHOLIPID; THROMBOPLASTIN; ANTICOAGULANT AGENT; GLYCOPROTEIN;

BLOOD CLOTTING; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; PRIORITY JOURNAL; ANIMAL; ARTICLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; MOUSE;

ANIMALS; ANTICOAGULANTS; BETA 2-GLYCOPROTEIN I; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VIIA; FACTOR XA; GLYCOPROTEINS; HUMANS; MICE; THROMBOPLASTIN;

EID: 0031595910     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995844     Document Type: Conference Paper

References (18)

1. Heimburger N, Heide K, Haupt H, Schultze HE. Bausteinanalysen von Human Serum Proteinen. Clin Chim Acta 1964;10: 293-302
2. Kroll J, Larsen JK, Loft H, et al. DNA binding proteins in Yoshida ascites tumor fluid. Biochim Biophys Acta 1976;434: 490-501
3. Polz E, Kostner GM. The binding of β2 glycoprotein-I to human serum lipoproteins: Distribution among density fractions. FEBS Lett 1979;102:183-186
4. Polz E, Wurm H, Kostner GM. Investigation on β2 glycoprotein-I in the rat: Isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem 1980;11:265-270
5. Schousboe I. Characterization of the interaction between β2 glycoprotein-I and mitochondria, platelets, liposomes and bile acids. Int J Biochem 1983;15:1393-1401
6. Nimpf J, Wurm H, Kostner GM. Interaction of β2 glycoprotein-I with human blood platelets: Influence upon ADP induced aggregation. Thromb Haemostas 1985;54:397-401
7. Schousboe I. β2 glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66:1086-1091
8. Nimpf J, Bevers EM, Bomans PHH, et al. Prothrombinase activity of human platelets is inhibited by β2 glycoprotein-I. Biochim Biophys Acta 1986;884:142-149
9. Mori T, Takeya H, Nishioka J, Gabazza EC, Suzuki K. β2-glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb Haemostas 1996; 75:49-55
10. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4124
11. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-1547
12. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-178
13. Shigematsu Y, Miyata T, Higashi S, et al. Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. J Biol Chem 1992;267:21329-21337
14. Takeya H, Mori T, Gabazza EC, et al. Anti-β2-glycoprotein I (β2-GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the β2-GPI binding to phospholipid. J Clin Invest 1997; 99:2260-2268
15. Stevenson KJ, Easton AC, Curry A, Thomson JM, Pollar L. The reliability of activated partial thromboplastin time methods and the relationship to lipid composition and ultrastructure. Thromb Haemostas 1986;55:250-258
16. Neuenschwander PF, Bianco-Fisher E, Rezaie AR, Morrissey JH. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: Enhancement of sensitivity to phosphatidylserine. Biochemistry 1995;34:13988-13993
17. Kornberg A, Blank M, Kaufman S, Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 1994;153:1328-1332
18. Shi W, Chong BH, Hogg PJ, Chesterman CN. Anticardiolipin antibodies block the inhibition by β2-glycoprotein I of the factor Xa generation activity of platelets. Thromb Haemostas 1993; 70:342-345